Free GLP-1 tool
GLP-1 Travel & Refrigerator Storage Calculator
Check the labeled storage window for the device in your hand — never another product’s rule.
What this result means
See the official refrigerator and room-temperature window for one exact presentation.
Each presentation has its own encoded official window. If the reported temperature exceeds the labeled maximum, or the window has elapsed, the tool stops and sends you to the pharmacist or prescriber.
What this tool cannot tell you
- Whether medication is safe after an unsupported temperature excursion.
- A room-temperature rule borrowed from another brand or device.
- Whether to use a pen that has been frozen.
Methodology & sources
Each presentation has its own encoded official window. If the reported temperature exceeds the labeled maximum, or the window has elapsed, the tool stops and sends you to the pharmacist or prescriber.
- WEGOVY (semaglutide) injection / tablet prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · 2026-06 · Last verified 2026-09-16
Used for Wegovy injection missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 to 7 weeks after the last 2.4 mg or 7.2 mg injection). Tablet rules are not encoded.
- OZEMPIC (semaglutide) injection prescribing information
U.S. National Library of Medicine DailyMed / Novo Nordisk · Last verified 2026-09-16
Used for Ozempic missed-dose, labeled weekly schedule, pen/syringe storage, and labeled injection pharmacokinetics (approximately 1-week half-life; present about 5 weeks after the last dose; steady state after 4 to 5 weekly doses).
- OZEMPIC (semaglutide) U.S. Prescribing Information
Novo Nordisk · Last verified 2026-09-16
- ZEPBOUND (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Zepbound missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-to-6-day half-life; steady state after 4 weekly doses).
- ZEPBOUND (tirzepatide) U.S. Prescribing Information
Eli Lilly and Company · Last verified 2026-09-16
- MOUNJARO (tirzepatide) injection prescribing information
U.S. National Library of Medicine DailyMed / Eli Lilly · Last verified 2026-09-16
Used for Mounjaro missed-dose, labeled weekly schedule, presentation-specific storage, and labeled injection pharmacokinetics (approximately 5-day half-life; steady state after 4 weekly doses).
Related WellForm MD resources
Need individualized guidance?
These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.
Book a free consultation